Bo Chen1, Yong Zhou, Ping Yang, Xiao-Ting Wu. 1. Department of Gastrointestinal Surgery, West China Hospital, Sichuan University, 37 Guo Xue Road, Chengdu, 610041 Sichuan Province, China.
Abstract
PURPOSE: Studies investigating the association between excision repair cross-complimentary group 2 (ERCC2) polymorphisms and gastric cancer (GC) risk have reported conflicting results. We performed a meta-analysis of published epidemiological studies to derive a more precise estimation of the relationship. METHODS: Published literature from PubMed, EMBASE, and China National Knowledge Infrastructure was retrieved. Ten studies with 2,141 GC cases and 5,343 controls were selected. RESULTS: No association between ERCC2 Lys751Gln polymorphism and GC susceptibility for all genetic models was found. When stratified by race, we found the Gln/Gln genotype carriers might be at high risk of GC among Asians, but not among Caucasians. Also, the pooled results showed there was a significant difference in genotype distribution between non-gastric cardia cancer cases and controls. For ERCC2 Asp312Asn polymorphism, significantly elevated GC risk was associated with Asn/Asn genotype (AA vs. GG + GA: OR = 1.36, 95%CI = 1.04-1.77, P = 0.02). We also found this genotype was associated with GC susceptibility among Asians and subjects without Helicobacter pylori infection. No publication bias was found in the present study. CONCLUSIONS: This meta-analysis concluded that both ERCC2 Lys751Gln and Asp312Asn polymorphisms might contribute to increased risk of GC among Asians.
PURPOSE: Studies investigating the association between excision repair cross-complimentary group 2 (ERCC2) polymorphisms and gastric cancer (GC) risk have reported conflicting results. We performed a meta-analysis of published epidemiological studies to derive a more precise estimation of the relationship. METHODS: Published literature from PubMed, EMBASE, and China National Knowledge Infrastructure was retrieved. Ten studies with 2,141 GC cases and 5,343 controls were selected. RESULTS: No association between ERCC2 Lys751Gln polymorphism and GC susceptibility for all genetic models was found. When stratified by race, we found the Gln/Gln genotype carriers might be at high risk of GC among Asians, but not among Caucasians. Also, the pooled results showed there was a significant difference in genotype distribution between non-gastric cardia cancer cases and controls. For ERCC2 Asp312Asn polymorphism, significantly elevated GC risk was associated with Asn/Asn genotype (AA vs. GG + GA: OR = 1.36, 95%CI = 1.04-1.77, P = 0.02). We also found this genotype was associated with GC susceptibility among Asians and subjects without Helicobacter pylori infection. No publication bias was found in the present study. CONCLUSIONS: This meta-analysis concluded that both ERCC2 Lys751Gln and Asp312Asn polymorphisms might contribute to increased risk of GC among Asians.
Authors: G S Winkler; S J Araújo; U Fiedler; W Vermeulen; F Coin; J M Egly; J H Hoeijmakers; R D Wood; H T Timmers; G Weeda Journal: J Biol Chem Date: 2000-02-11 Impact factor: 5.157
Authors: Ilir Agalliu; Erika M Kwon; Claudia A Salinas; Joseph S Koopmeiners; Elaine A Ostrander; Janet L Stanford Journal: Cancer Causes Control Date: 2009-11-10 Impact factor: 2.506
Authors: Huanting Liu; Jana Rudolf; Kenneth A Johnson; Stephen A McMahon; Muse Oke; Lester Carter; Anne-Marie McRobbie; Sara E Brown; James H Naismith; Malcolm F White Journal: Cell Date: 2008-05-30 Impact factor: 41.582
Authors: Gabriel Capellá; Guillem Pera; Núria Sala; Antonio Agudo; Francisco Rico; Giuseppe Del Giudicce; Mario Plebani; Domenico Palli; Heiner Boeing; H Bas Bueno-de-Mesquita; Fátima Carneiro; Franco Berrino; Paolo Vineis; Rosario Tumino; Salvatore Panico; Göran Berglund; Henrik Simán; Olof Nyrén; Goran Hallmans; Carmen Martinez; Miren Dorronsoro; Aurelio Barricarte; Carmen Navarro; José R Quirós; Naomi Allen; Tim Key; Sheila Bingham; Carlos Caldas; Jakob Linseisen; Gabriele Nagel; Kim Overvad; Anne Tjonneland; Hendriek C Boshuizen; Petra H M Peeters; Mattijs E Numans; Françoise Clavel-Chapelon; Antonia Trichopoulou; Eiliv Lund; Mazda Jenab; Rudolf Kaaks; Elio Riboli; Carlos A González Journal: Int J Epidemiol Date: 2008-07-19 Impact factor: 7.196